Company · CIK 0001613103 · SIC 3845 — Electromedical & Electrotherapeutic Apparatus · NYSE
Medtronic plc · MDT
Insider activity reported against this company. All insider holders · Files at: INSP. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 SForm 4 → | Sep 17, 4:17 pm EDT | Harry Skip KiilEVP & President Cardiovascular | 1,483 | $93.65 | $138,883 | 42,186 | −3.40% | |
| Sep 15, 2026 GForm 4 → | Sep 16, 4:16 pm EDT | Denise L. BlomquistChief Accounting Officer | 600 | — | — | 16,398 | — | |
| Aug 20, 2026 FForm 4 → | Aug 24, 5:04 pm EDT | Michael MarinaroEVP, Pres MedSurg and Americas | 1,084 | $92.30 | $100,053 | 116,336 | — | |
| Aug 3, 2026 AForm 4 → | Aug 4, 7:59 pm EDT | Michelle QuinnEVP, GC and Secretary | 6,346 | — | — | 26,721 | — | |
| Aug 3, 2026 AForm 4 → | Aug 4, 7:59 pm EDT | Thierry PietonEVP & Chief Financial Officer | 11,537 | — | — | 49,645 | — | |
| Jul 31, 2026 AFForm 4 → | Aug 4, 8:00 pm EDT | Denise L. BlomquistChief Accounting Officer | 2,549 | $85.39 | $18,103 | 16,998 | — | |
| Jul 31, 2026 AFForm 4 → | Aug 4, 8:00 pm EDT | Matthew R. WalterSVP, Chief HR Officer | 7,444 | $85.39 | $143,028 | 39,928 | — | |
| Jul 31, 2026 AFForm 4 → | Aug 4, 7:59 pm EDT | Kweli ThompsonEVP & President, Neuroscience | 8,662 | $85.39 | $148,493 | 35,390 | — | |
| Jul 31, 2026 AFForm 4 → | Aug 4, 7:58 pm EDT | Michael MarinaroEVP, Pres MedSurg and Americas | 60,463 | $85.39 | $286,569 | 117,420 | — | |
| Jul 31, 2026 AFForm 4 → | Aug 4, 7:58 pm EDT | Harry Skip KiilEVP & President Cardiovascular | 12,304 | $85.39 | $262,489 | 43,669 | — | |
| Jul 31, 2026 AFForm 4 → | Aug 4, 7:57 pm EDT | Geoffrey MarthaChairman and CEO, Director | 57,343 | $85.39 | $1,350,016 | 327,866 | — | |
| Jul 28, 2026 FForm 4 → | Jul 29, 5:00 pm EDT | Michelle QuinnEVP, GC and Secretary | 2,069 | $86.88 | $179,755 | 20,375 | — | |
| Jul 8, 2026 SForm 4 → | Jul 9, 4:26 pm EDT | Matthew R. WalterSVP, Chief HR Officer | 3,102 | $83.15 | $257,931 | 35,694 | −8.00% | 10b5-1 |
| Jun 8, 2026 SForm 4 → | Jun 9, 4:16 pm EDT | Harry Skip KiilEVP & President Cardiovascular | 4,189 | $80.44 | $336,965 | 37,227 | −10.1% | |
| Jun 5, 2026 FForm 4 → | Jun 8, 5:01 pm EDT | Denise L. BlomquistChief Accounting Officer | 237 | $83.32 | $19,747 | 14,737 | — | |
| Jun 4, 2026 FForm 4 → | Jun 8, 5:07 pm EDT | Harry Skip KiilEVP & President Cardiovascular | 6,817 | $83.32 | $567,992 | 41,416 | — | |
| Jun 4, 2026 FForm 4 → | Jun 8, 5:03 pm EDT | Geoffrey MarthaChairman and CEO, Director | 41,936 | $83.32 | $3,494,108 | 301,163 | — | |
| Jun 4, 2026 FForm 4 → | Jun 8, 5:02 pm EDT | Michael MarinaroEVP, Pres MedSurg and Americas | 7,471 | $83.32 | $622,484 | 63,122 | — | |
| Jun 4, 2026 FForm 4 → | Jun 8, 5:02 pm EDT | Matthew R. WalterSVP, Chief HR Officer | 2,840 | $83.32 | $236,629 | 38,689 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 AForm 4 → | Aug 4, 8:00 pm EDT | Denise L. BlomquistChief Accounting Officer | 3,703 | — | — | 1,366 | — | |
| Aug 3, 2026 AForm 4 → | Aug 4, 8:00 pm EDT | Matthew R. WalterSVP, Chief HR Officer | 55,394 | — | — | 40,973 | — | |
| Aug 3, 2026 AForm 4 → | Aug 4, 7:59 pm EDT | Kweli ThompsonEVP & President, Neuroscience | 66,473 | — | — | 49,167 | — | |
| Aug 3, 2026 AForm 4 → | Aug 4, 7:59 pm EDT | Michelle QuinnEVP, GC and Secretary | 60,933 | — | — | 45,070 | — | |
| Aug 3, 2026 AForm 4 → | Aug 4, 7:59 pm EDT | Thierry PietonEVP & Chief Financial Officer | 110,787 | — | — | 81,945 | — | |
| Aug 3, 2026 AForm 4 → | Aug 4, 7:58 pm EDT | Michael MarinaroEVP, Pres MedSurg and Americas | 105,248 | — | — | 77,848 | — | |
| Aug 3, 2026 AForm 4 → | Aug 4, 7:58 pm EDT | Harry Skip KiilEVP & President Cardiovascular | 88,630 | — | — | 65,556 | — | |
| Aug 3, 2026 AForm 4 → | Aug 4, 7:57 pm EDT | Geoffrey MarthaChairman and CEO, Director | 671,983 | — | — | 273,150 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.